IIM
ABBV icon

Ipswich Investment Management’s AbbVie ABBV Stock Holding History

Ipswich Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.99M Buy
11,896
+200
+2% +$43K 0.63% 38
2026
Q1 		$2.54M Buy
11,696
+1,017
+10% +$226K 0.6% 41
2025
Q4 		$2.44M Sell
10,679
-5
-0% -$1.14K 0.57% 43
2025
Q3 		$2.47M Sell
10,684
-1,054
-9% -$215K 0.58% 42
2025
Q2 		$2.18M Sell
11,738
-2,725
-19% -$506K 0.53% 44
2025
Q1 		$3.03M Sell
14,463
-2,335
-14% -$454K 0.75% 38
2024
Q4 		$2.99M Sell
16,798
-1,200
-7% -$221K 0.72% 40
2024
Q3 		$3.55M Sell
17,998
-19,650
-52% -$3.67M 0.82% 36
2024
Q2 		$6.46M Sell
37,648
-50
-0.1% -$8.28K 1.51% 21
2024
Q1 		$6.86M Sell
37,698
-100
-0.3% -$17.2K 1.61% 21
2023
Q4 		$5.86M Hold
37,798
– – 1.48% 20
2023
Q3 		$5.63M Sell
37,798
-600
-2% -$88.1K 1.54% 19
2023
Q2 		$5.17M Sell
38,398
-180
-0.5% -$26.4K 1.36% 21
2023
Q1 		$6.15M Buy
38,578
+535
+1% +$81.8K 1.68% 11
2022
Q4 		$6.15M Buy
38,043
+12
+0% +$1.84K 1.76% 11
2022
Q3 		$5.1M Sell
38,031
-290
-0.8% -$41.6K 1.62% 13
2022
Q2 		$5.87M Sell
38,321
-2,066
-5% -$316K 1.69% 12
2022
Q1 		$6.55M Buy
40,387
+290
+0.7% +$42.1K 1.63% 14
2021
Q4 		$5.43M Buy
40,097
+1,180
+3% +$139K 1.27% 19
2021
Q3 		$4.2M Buy
38,917
+120
+0.3% +$13.7K 1.07% 27
2021
Q2 		$4.37M Sell
38,797
-500
-1% -$56.3K 1.12% 25
2021
Q1 		$4.25M Sell
39,297
-200
-0.5% -$21.4K 1.2% 23
2020
Q4 		$4.23M Buy
39,497
+237
+0.6% +$22.8K 1.27% 22
2020
Q3 		$3.44M Sell
39,260
-175
-0.4% -$16.5K 1.1% 33
2020
Q2 		$3.87M Buy
39,435
+576
+1% +$50.7K 1.33% 20
2020
Q1 		$2.96M Buy
38,859
+154
+0.4% +$13.1K 1.16% 29
2019
Q4 		$3.43M Buy
38,705
+925
+2% +$76.8K 1.01% 36
2019
Q3 		$2.86M Sell
37,780
-220
-0.6% -$15.1K 0.91% 40
2019
Q2 		$2.76M Buy
38,000
+1,315
+4% +$103K 0.88% 39
2019
Q1 		$2.96M Buy
36,685
+3,930
+12% +$322K 0.97% 35
2018
Q4 		$3.02M Sell
32,755
-120
-0.4% -$10.6K 1.11% 28
2018
Q3 		$3.11M Buy
32,875
+2,920
+10% +$277K 1.05% 30
2018
Q2 		$2.77M Buy
29,955
+26,055
+668% +$2.54M 1.28% 29
2018
Q1 		$369K Sell
3,900
-500
-11% -$54.9K 0.16% 108
2017
Q4 		$426K Sell
4,400
-20
-0.5% -$1.89K 0.18% 101
2017
Q3 		$393K Sell
4,420
-50
-1% -$3.81K 0.18% 96
2017
Q2 		$324K Buy
+4,470
New +$301K 0.15% 103
2016
Q2 		– Sell
-2,900
Closed -$185K – 137
2016
Q1 		$185K Sell
2,900
-27,855
-91% -$1.55M 0.09% 127
2015
Q4 		$1.82M Sell
30,755
-6,395
-17% -$368K 0.82% 45
2015
Q3 		$2.02M Buy
37,150
+3,940
+12% +$256K 0.96% 42
2015
Q2 		$2.23M Sell
33,210
-1,650
-5% -$108K 1.01% 41
2015
Q1 		$2.04M Buy
34,860
+8,160
+31% +$493K 0.89% 44
2014
Q4 		$1.75M Buy
+26,700
New +$1.68M 0.74% 47
2014
Q3 		– Sell
-3,875
Closed -$219K – 134
2014
Q2 		$219K Sell
3,875
-975
-20% -$51.1K 0.08% 132
2014
Q1 		$249K Sell
4,850
-900
-16% -$45.5K 0.11% 104
2013
Q4 		$304K Sell
5,750
-100
-2% -$4.92K 0.13% 109
2013
Q3 		$262K Hold
5,850
– – 0.12% 113
2013
Q2 		$242K Buy
+5,850
New +$256K 0.1% 126

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Ipswich Investment Management's ABBV Position: Q2 2026 in Review

Ipswich Investment Management increased its AbbVie (ABBV) stake by 1.7% in Q2 2026, buying an estimated $43K and bringing the position to 11,896 shares worth $2.99M. The position accounts for 0.63% of the portfolio, ranked #38.

Ipswich Investment Management first reported a position in ABBV in Q2 2013 and has held it in 48 quarters since. The position peaked at $6.86M in Q1 2024. 1,174 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Ipswich Investment Management held 11,896 shares of AbbVie worth $2.99M as of Q2 2026.
  • Ipswich Investment Management bought 200 AbbVie shares in Q2 2026, an estimated $43K.
  • AbbVie made up 0.63% of Ipswich Investment Management's portfolio in Q2 2026, its #38 holding.
  • Ipswich Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 48 quarters since.
  • Ipswich Investment Management's AbbVie position peaked at $6.86M in Q1 2024.
  • 1,174 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ipswich Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.